Esperion Therapeutics, Inc.·4

Mar 15, 4:35 PM ET

Warren Eric 4

4 · Esperion Therapeutics, Inc. · Filed Mar 15, 2024

Insider Transaction Report

Form 4
Period: 2024-03-14
Warren Eric
Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2024-03-14+100,000168,318 total
  • Award

    Stock Option (right to buy)

    2024-03-14+150,000150,000 total
    Exercise: $2.05Exp: 2034-03-14Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which will be on June 15, 2024.

Documents

2 files